dipyridamole has been researched along with Pulmonary Fibrosis in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of dipyridamole (DPM) and adenosine (ADO) on interstitial pulmonary fibrosis in mice." | 7.71 | [The effect of dipyridamole and adenosine on pulmonary fibrosis in mice]. ( Chen, L; Liu, X; Lou, W; Pan, J, 2002) |
| "To evaluate the effect of dipyridamole (DPM) and adenosine (ADO) on interstitial pulmonary fibrosis in mice." | 3.71 | [The effect of dipyridamole and adenosine on pulmonary fibrosis in mice]. ( Chen, L; Liu, X; Lou, W; Pan, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, J | 1 |
| Lou, W | 1 |
| Chen, L | 1 |
| Liu, X | 1 |
1 other study available for dipyridamole and Pulmonary Fibrosis
| Article | Year |
|---|---|
[The effect of dipyridamole and adenosine on pulmonary fibrosis in mice].
Topics: Adenosine; Animals; Bleomycin; Cell Count; Dipyridamole; Lung; Macrophages, Alveolar; Mice; Microsco | 2002 |